Tocqueville Asset Management L.P. Voyager Therapeutics, Inc. Transaction History

Tocqueville Asset Management L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 14, 2020	SELL	$12.82 - $16.85 $367,357 - $482,836	-28,655 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$16.31 - $28.29 $95,087 - $164,930	5,830 Added 25.54%	28,655 $493,000
Q2 2019 Jul 31, 2019	SELL	$19.18 - $27.88 $145,768 - $211,888	-7,600 Reduced 24.98%	22,825 $621,000
Q1 2019 Apr 30, 2019	BUY	$8.0 - $19.66 $19,400 - $47,675	2,425 Added 8.66%	30,425 $582,000
Q4 2018 Feb 08, 2019	SELL	$8.59 - $18.05 $168,149 - $353,328	-19,575 Reduced 41.15%	28,000 $263,000
Q3 2018 Nov 13, 2018	BUY	$17.11 - $21.74 $179,655 - $228,269	10,500 Added 28.32%	47,575 $900,000
Q2 2018 Aug 13, 2018	BUY	$16.76 - $23.92 $123,186 - $175,812	7,350 Added 24.73%	37,075 $724,000
Q4 2017 Feb 13, 2018	BUY	$12.26 - $25.88 $364,428 - $769,283	29,725	29,725 $493,000

134

34.1M

60.4K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $151M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.